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Metformin, which acts by decreasing hepatic glucose
production and increasing its peripheral utilization
[1], is the most widely used oral antidiabetic agent in
the world. It is the first choice of treatment for patients
with type 2 diabetes. Lactic acidosis, which is defined
as a blood lactate level greater than 5 mmol/L and a
blood pH below 7.35 [2], is a rare but potentially fatal
adverse effect of metformin with an estimated risk of
1–15 cases per 100,000 patient-years [3,4] and a reported
mortality of up to 50% [4,5]. Metformin-induced lactic
acidosis is usually thought to result from an intracel-
lular shift to anaerobic metabolism, which results in
massive lactate accumulation and impaired utilization
of glucose due to suppression of hepatic gluconeoge-
nesis. The net result is an accumulation of lactate in
the circulatory system, terminating in lactic acidosis.
This may occur in patients with chronic renal function
impairment, or may be precipitated acutely by co-
morbidities such as dehydration, shock, sepsis, acute
myocardial infarction, cardiac failure, liver disease,
and intravascular administration of iodinated con-
trast agents. All of these factors have the potential to
alter renal function or cause tissue hypoxia [6,7].
Here, we report a diabetic patient with an episode
of severe lactic acidosis, shock and hypoglycemia
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Metformin-associated lactic acidosis is a very rare but critical condition. It is seen in patients with
type 2 diabetes mellitus who take metformin and attempt suicide with a metformin overdose.
Here, we report a 43-year-old woman with type 2 diabetes mellitus and chronic renal insufficiency
who developed hypoglycemia, hypothermia, tachycardia and lactic acidosis after a suicide attempt
with a metformin overdose. She was successfully treated by continuous venovenous hemofiltra-
tion, and adequate hemodynamic and ventilatory support. Although metformin does not usually
cause hypoglycemia when administered as monotherapy, hypoglycemia can occur in a condition
coexistent with lactic acidosis secondary to metformin overdose. Metformin intoxication should
be suspected when patients present with high anion gap metabolic acidosis after attempting sui-
cide by ingesting drugs, particularly when comorbidities such as renal failure are present. Early
diagnosis and rapid correction of the metabolic acidosis using hemodialysis or hemofiltration,
together with concomitant cardiovascular support, and maintenance of blood glucose and core
body temperature, provide the possibility of a positive outcome.
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after attempting suicide with a metformin overdose.
She was successfully resuscitated by hemodynamic
stabilization, ventilatory support and continuous ven-
ovenous hemofiltration. This experience reminds cli-
nicians that lactic acidosis should be considered in
patients with profound metabolic acidosis, or abdom-
inal or respiratory distress.
CASE PRESENTATION
A 43-year-old woman with type 2 diabetes presented
in the emergency room with poor appetite and olig-
uria for 3 days. On the day of arrival, she experienced
lethargy. The patient’s caregiver reported that the
patient had a depressive mood, and had attempted
suicide by ingesting an unknown number of metfor-
min tablets on the day of arrival. She was sent to an-
other local hospital first with a diagnosis of metformin
overdose and then referred to our institution. She had
a history of type 2 diabetes mellitus for 10 years, which
was controlled with metformin, 500 mg twice daily,
and she was found to have diabetic nephropathy dur-
ing the follow-up period.
On arrival, her consciousness level was E1V1M1
on the Glasgow coma scale (GCS), and her blood
pressure was 115/59 mmHg, pulse rate was 132 beats/
minute, respiration rate was 18 breaths/minute, and
temperature was 30°C. Laboratory studies revealed a
blood glucose level of 17 mg/dL, blood urea nitrogen
(BUN) of 75mg/dL (reference range, 5–20mg/dL), cre-
atinine of 8.1 mg/dL (reference range, 0.5–1.5 mg/dL),
sodium (Na+) of 133.0 mmol/L (reference range, 135–
150mmol/L), potassium (K+) of 7.2mmol/L (reference
range, 3.5–5 mmol/L), chloride (Cl−) of 81.0 mmol/L
(reference range, 99–111 mmol/L), and lactate of
5.01 mmol/L (reference range, 0.7–2.1 mmol/L). The
urine ketone level was negative and glycosylated
hemoglobin (HbA1C) was 5.7%. The patient’s arterial
blood gas levels in room air were pH 6.989, PO2
99 mmHg, PCO2 48.7 mmHg, HCO3– 11.8 mmol/L
and SaO2 92.5%. The anion gap, defined as [Na+]−
[Cl−]–[HCO3−], was 40.2 mmol/L.
Intravenous glucose (20 g) was prescribed to cor-
rect the hypoglycemia, but her consciousness level
did not improve significantly. Sixty grams of acti-
vated charcoal was administrated via a nasogastric
tube. Calcium gluconate (10%; 10 mL) was given to
counteract hyperkalemia. Sodium bicarbonate was
infused at a rate of 40 mL/hour in an attempt to cor-
rect her severe metabolic acidosis. Passive external
re-warming therapy was started for hypothermia.
Because her blood pressure dropped to 68/34 mmHg
within the first 2 hours, dopamine was administered
at a rate of 12 μg/kg/minute and norepinephrine was
given at a rate of 25 μg/kg/minute.
Her respiratory function subsequently worsened
and she was intubated for ventilatory support. On
arrival, intermittent hemodialysis was performed for
2 hours with a blood flow of 220 mL/minute to
remove potassium, lactate and metformin from the
circulation. However, her hemodynamic instability
worsened, with blood pressure decreasing to
64/43 mmHg while on hemodialysis. Her plasma 
lactate concentration increased to 21.60 mmol/L and
39.30 mmol/L within the first 12 and 20 hours,
respectively. Deterioration of metabolic acidosis 
(pH 7.105, HCO3− 4.7 mmol/L) persisted even after
12 hours of continuous sodium bicarbonate infusion.
Twenty hours later, continuous venovenous hemofil-
tration (CVVH), via a double-lumen femoral dialysis
line, was started at a blood flow of 180 mL/minute.
CVVH was replaced with CVVH A solution, con-
taining Na+ 147.2 mmol/L, Cl− 155.26 mmol/L, Ca2+
5.2 mmol/L, and Mg2+ 2.86 mmol/L, at a rate of
500 mL/hour, and CVVH B solution, containing 
Na+ 68.7 mmol/L, Cl− 35.42 mmol/L, and HCO3−
33.33 mmol/L, at a rate of 500 mL/hour. The lactate
levels decreased after initial hemofiltration, with lev-
els of 29.6 mmol/L and 20.8 mmol/L at 24 and 28
hours, respectively. Nevertheless, a further increase
in serum lactate was observed at 32 hours, with a 
lactate level of 30.6 mg/dL. The CVVH significantly
corrected the lactic acidosis and her lactate level
decreased to 25.85 mmol/L at 36 hours.
The patient exhibited normal consciousness on
hospital day 2. CVVH was continued for 60 hours
and then discontinued on hospital day 4. On hospital
day 4, artificial ventilation was withdrawn, the lactic
acidosis was corrected and the anion gap was normal-
ized. Subsequently, the blood glucose concentration
was controlled in the range of 127 and 203 mg/dL by
insulin injections. She was discharged on hospital day
8 with a BUN level of 59 mg/dL, a creatinine level of
6.2 mg/dL, and an estimated glomerular filtration
rate of 12.1mL/minute. Intermittent hemodialysis was
advised and she received subsequent treatment at 
a referral hospital.
DISCUSSION
This case demonstrates that although lactate levels
may be only mildly elevated on arrival in the emer-
gency department, serial follow-up of lactate levels
can confirm a diagnosis of metformin-associated lactic
acidosis. Metformin intoxication should be suspected
in a diabetic patient with high anion gap metabolic
acidosis. Appropriate laboratory evaluation is neces-
sary to clarify the diagnosis in patients with an uncer-
tain medical history or an overdose of an unknown
drug. Although the patient’s baseline renal function
and lactic acid level were not known, the manifestation
of oliguria for 3 days indicated acute deterioration 
of renal function. The severe renal failure probably
contributed to the severe metabolic acidosis, but the
increasing lactic acidosis was triggered by metformin
intoxication. Moreover, circulation failure may worsen
acidosis through reduced tissue perfusion and in-
creased lactate production. It is interesting that a fur-
ther increase in serum lactate was observed in our
patient during the initial hemofiltration treatment.
Metformin, tissue hypoxia, and bicarbonate adminis-
tration contributed to the subsequent increase in blood
lactate [8]. Despite hemofiltration, the production of
lactate can be greater than its elimination during severe
metformin intoxication. Hemodialysis or hemofiltra-
tion should be continued even if lactate levels rise
during treatment [9].
Metformin does not usually cause hypoglycemia
when administered as monotherapy, but hypoglyce-
mia can occur in the setting of metformin-associated
lactic acidosis [9,10]. Drug-induced hypoglycemia is
possible even in patients with diabetes who do not use
insulin or oral antidiabetic agents to increase insulin
secretion. The risk of metformin-induced hypoglyce-
mia should be considered, particularly when drugs
directly stimulating insulin secretion, strenuous phys-
ical activity, fasting, or comorbidities such as renal
failure are combined [11,12]. We speculated that the
hypoglycemia in this patient was caused by the addi-
tional blood glucose-lowering effects from poor food in-
take and renal failure. Moreover, lactic acidosis during
metformin use is very rare without underlying co-
morbidities such as chronic kidney disease or myocar-
dial infarction, which can contribute to lactic acidosis
even without metformin use [11,12]. Clinicians should
also treat the comorbidities contributing to hypoglyce-
mia and lactic acidosis in addition to management of 
metformin intoxication. Our patient also had a depres-
sive mood. Depression is associated with poor adher-
ence to medical regimens and increased mortality [13].
The initial management of metformin toxicity is
directed at support of ventilation and circulation.
Gastrointestinal decontamination should be consid-
ered if recent ingestion is suspected. It should also be
noted that our patient was hypothermic upon arrival.
This was probably related to the lactic acidosis and
severe hypoglycemia. Maintenance of body tempera-
ture is important in patients with severe lactic acidosis
secondary to metformin. The use of bicarbonate should
be considered in well-ventilated patients with a pH <
7.0. Because sodium bicarbonate infusions alone are
not able to sufficiently correct the acid-base metabo-
lism, hemodialysis is recommended for the clearance
of metformin and to treat the acidosis. Lactate and met-
formin can be readily removed from the circulation by
intermittent hemodialysis, while CVVH is considered
superior to intermittent hemodialysis with respect to
hemodynamic stability. Moreover, a combination of
intermittent hemodialysis with high-volume CVVH
using two vascular access sites has been reported in
the successful treatment of severe metformin-induced
lactic acidosis [14]. Bicarbonate can easily cross the
dialysis membrane, and bicarbonate dialysis can rap-
idly correct acid-base disorders in addition to remov-
ing metformin [15,16]. Because metformin is easily
dialyzed, hemoperfusion using a charcoal filter alone
without hemodialysis should not be used to clear met-
formin because it cannot correct acid-base disorders.
Our patient was too hemodynamically unstable to
tolerate hemodialysis; thus, CVVH was the preferred
treatment [17]. Because of the wide distribution of
metformin, hemodialysis or hemoperfusion should
be continued to maximize metformin removal.
Contraindications are often neglected in clinical
practice [18] and in one study, approximately 25% 
of patients taking metformin had at least one con-
traindication to its use [19]. Severe lactic acidosis can
develop in patients without known contraindications
for metformin, if they are taking high doses of met-
formin [20]. According to the manufacturer, the risk of
metformin-associated lactic acidosis in patients with-
out impaired renal function and other contraindications
is very low and only a few cases have been reported.
However, it is necessary for clinicians to estimate the
glomerular filtration rate of patients with diabetes
annually, especially patients using metformin.
Metformin-associated lactic acidosis
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Our case experience demonstrates that metformin
intoxication should be suspected in patients with dia-
betes who have wide anion-gap metabolic acidosis sec-
ondary to a suicide attempt by drug overdose. Because
metformin-associated hypoglycemia, hypothermia and
lactic acidosis are reversible, early diagnosis and treat-
ment of metabolic acidosis using hemodialysis or
hemofiltration, together with concomitant cardiovas-
cular support, maintenance of blood glucose, and
stabilization of the core body temperature, provide
the possibility of a good outcome.
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乳酸血症是 metformin 治療第二型糖尿病或服藥過量意圖自殺時少見但嚴重的併發
症。我們報告一位第二型糖尿病合併慢性腎衰竭的病患，服用 metformin 自殺後發
生低血糖、低體溫、心搏過速與持續惡化之乳酸血症。此病患僅單純服用 metformin 
卻發生低血糖，利用連續性靜脈對靜脈血液過濾治療時，初期仍然持續有乳酸升高情
形。當預存有慢性疾病的病患意圖自殺、服藥過量而出現高陰離子間隙代謝性酸中毒
時，應考慮是 metformin 過量。早期診斷，儘早使用血液透析或血液過濾，同時穩
定血壓、給予矯正低血糖與低體溫等支持治療，可以改善預後。
關鍵詞：糖尿病，低血糖，乳酸血症，metformin
(高雄醫誌 2009;25:93–7)
